ARWR vs ES · rev $829.4M vs P/E 28, rev $7.41B
Arrowhead Pharmaceuticals Inc (ARWR) versus Eversource Energy (ES) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Eversource Energy (ES) is a utilities - regulated electric company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported ES revenue for 2026-06-30 was $7.41B. Net income was $664.3M. Revenue was up 64.5% from 2026-03-31 to 2026-06-30. ES currently screens at market cap $23.72B and trailing P/E 28.3.
ARWR currently screens at market cap $10.59B. ES currently screens at market cap $23.72B and trailing P/E 28.3.
Not investment advice. Open the ARWR and ES stock pages for the full models.
Not investment advice.